Testing effectiveness (Phase 2)Study completedNCT03374657
What this trial is testing
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
Who this might be right for
Retinitis Pigmentosa
Novartis Pharmaceuticals 12